04.06.17
At INDEX, Avgol introduced its new Skinguard topsheet material for the global adult incontinence market. The fabric is treated with copper oxide to stimulate the production of collagen and other key proteins, stabilize skin layers and improve the look of skin. The result is advanced skin protection and enhancement, improved odor control and long lasting effect throughout the life of the product.
Skinguard is just a part of Avgol’s innovative range of nonwovens for the hygiene market including products for baby diapers, adult incontinence and feminine hygiene products.
“Nonwovens are extraordinarily versatile materials and our nonwoven fabric solutions are designed and manufactured according to changing market demands,” says vice president of sales Gilad Frenkel. “Avgol continues delivering added values to our customers in its innovation, service and qualities as our customers are our focus.”
Key to Avgol’s success is its ambitious investment record, which most recently has included the creation of a new manufacturing site in Dimona, Israel, a $60 million investment designed to grow the company’s customer base in Europe, the Middle East, Africa and South America. The line should be fully commercialized by July 2017.
Skinguard is just a part of Avgol’s innovative range of nonwovens for the hygiene market including products for baby diapers, adult incontinence and feminine hygiene products.
“Nonwovens are extraordinarily versatile materials and our nonwoven fabric solutions are designed and manufactured according to changing market demands,” says vice president of sales Gilad Frenkel. “Avgol continues delivering added values to our customers in its innovation, service and qualities as our customers are our focus.”
Key to Avgol’s success is its ambitious investment record, which most recently has included the creation of a new manufacturing site in Dimona, Israel, a $60 million investment designed to grow the company’s customer base in Europe, the Middle East, Africa and South America. The line should be fully commercialized by July 2017.
